5 Patents
- US120247082024ANGPTL4 Oligonucleotides Influencing the Regulation of the Fatty Acid Metabolism
LIPIGON PHARMACEUTICALS AB
0 cites - US119590832024Immunosuppression-reverting Oligonucleotides Inhibiting the Expression of CD39
Secarna Pharmaceuticals GmbH & Co. KG
0 cites - US117811362023Oligonucleotide Inhibiting the Expression of Chop
Secarna Pharmaceuticals GmbH & Co. KG
0 cites - US117811392023ANGPTL4 Oligonucleotides Influencing the Regulation of the Fatty Acid Metabolism
Lipigon Pharmaceuticals AB
0 cites - US116665952023Antisense Oligonucleotides for Inhibition of PD-L1 Expression and Treating Cancer
Secarna Pharmaceuticals GmbH & Co. KG
0 cites